Abstract
Mutations in the valosin-containing protein (VCP) gene have been linked to amyotrophic lateral sclerosis (ALS) in the Caucasian populations. However, the phenotype of VCP mutations in Chinese patients with (ALS) remains unclear. Targeted next-generation sequencing covered 28 ALS-related genes including the VCP gene was undertaken to screen in a Chinese cohort of 275 sporadic ALS cases and 15 familial ALS pedigrees. An extensive literature review was performed to identify all patients with ALS carrying VCP mutations previously reported. The clinical characteristics and genetic features of ALS patients with VCP mutations were reviewed. One known p.R155C mutation in the VCP gene was detected in two siblings from a familial ALS pedigree and two sporadic individuals. In addition, the same VCP p.R155C mutation was detected in an additional patient with ALS referred in 2021. Three patients with VCP p.R155C mutation presented with muscular weakness starting from proximal extremities to distal extremities. The other patient developed a phenotype of Paget's disease of bone in addition to the progressive muscular atrophy. We reported the first VCP mutation carrier manifesting ALS with Paget's disease of bone in the Chinese population. Our findings expand the phenotypic spectrum of the VCP mutations in Chinese patients with ALS and suggest that ALS patients with VCP p.R155C mutations tend to present with relatively young onset, symmetrical involvement of proximal muscles weakness of arms or legs, and then progressed to distal muscles of limbs.
Highlights
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by motor dysfunction in limbs and bulbar palsy, such as dysarthria and dysphagia
The same valosin-containing protein (VCP) p.R155C mutation was detected in the additional patient referred to Fujian Medical University Union Hospital in 2021
We reported the phenotype of four patients carrying the known VCP p.R155C mutation, such as two siblings from a familial ALS pedigree and a sporadic individual
Summary
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by motor dysfunction in limbs (muscle weakness, atrophy, and spasticity) and bulbar palsy, such as dysarthria and dysphagia. Cognitive decline or behavioral impairment occurs in some cases. Approximate two-thirds of patients with ALS had a limb onset. The typical disease course of ALS cases is aggressive, ending in death due to respiratory failure within 3–5 years [1]. 5–10% of ALS cases present in a familial pattern, while the others have no family history. The genetic background of ALS is complicated, correlated with a growing spectrum of genes, such as C9orf, SOD1, FUS, and TDP-43 [1]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.